000186219 001__ 186219
000186219 005__ 20240229145736.0
000186219 0247_ $$2doi$$a10.20892/j.issn.2095-3941.2022.0397
000186219 0247_ $$2pmid$$apmid:36476570
000186219 0247_ $$2altmetric$$aaltmetric:139913845
000186219 037__ $$aDKFZ-2022-03016
000186219 041__ $$aEnglish
000186219 082__ $$a610
000186219 1001_ $$0P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9$$aChen, Xuechen$$b0$$eFirst author$$udkfz
000186219 245__ $$aThe power of a healthy lifestyle for cancer prevention: the example of colorectal cancer.
000186219 260__ $$aTianjin$$bMedical Univ. Cancer Inst. & Hospital$$c2022
000186219 3367_ $$2DRIVER$$aarticle
000186219 3367_ $$2DataCite$$aOutput Types/Journal article
000186219 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670849074_19724
000186219 3367_ $$2BibTeX$$aARTICLE
000186219 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000186219 3367_ $$00$$2EndNote$$aJournal Article
000186219 500__ $$a#EA:C070#LA:C070#LA:C120#
000186219 520__ $$aWe aimed to directly compare the estimated effects of adherence to a healthy lifestyle with those of risk predisposition according to known genetic variants affecting colorectal cancer (CRC) risk, to support effective risk communication for cancer prevention.A healthy lifestyle score (HLS) was derived from 5 lifestyle factors: smoking, alcohol consumption, diet, physical activity, and body adiposity. The association of lifestyle and polygenic risk score (PRS) (based on 140 CRC-associated risk loci) with CRC risk was assessed with multiple logistic regression and compared through the genetic risk equivalent (GRE), a novel approach providing an estimate of the effects of adherence to a healthy lifestyle in terms of percentile differences in PRS.A higher HLS was associated with lower CRC risk (4,844 cases, 3,964 controls). Those adhering to all 5 healthy lifestyle factors had a 62% (95% CI 54%-68%) lower CRC risk than those adhering to ≤ 2 healthy lifestyle factors. The estimated effect of adherence to all 5 compared with ≤ 2 healthy lifestyle factors was as strong as the effect of having a 79 percentile (GRE 79, 95% CI 61-97) lower PRS. The association between a healthy lifestyle and CRC risk was independent of PRS level but was particularly pronounced among those with a family history of CRC in ≥ 1 first-degree relative (P-interaction = 0.0013).A healthy lifestyle was strongly inversely associated with CRC risk. The large GRE indicated that CRC risk determined by polygenic risk may be offset to a substantial extent by adherence to a healthy lifestyle.
000186219 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000186219 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000186219 650_7 $$2Other$$aColorectal cancer
000186219 650_7 $$2Other$$afamily history
000186219 650_7 $$2Other$$agenetic risk equivalent
000186219 650_7 $$2Other$$ahealthy lifestyle score
000186219 650_7 $$2Other$$apolygenic risk score
000186219 7001_ $$0P:(DE-He78)0d94e103911be59650920a32e859c2ba$$aDing, Jie$$b1$$udkfz
000186219 7001_ $$0P:(DE-He78)40c45b31a82f8311dd3a7363bd758720$$aLi, Hengjing$$b2$$udkfz
000186219 7001_ $$aCarr, Prudence R$$b3
000186219 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b4$$udkfz
000186219 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000186219 773__ $$0PERI:(DE-600)2676322-9$$a10.20892/j.issn.2095-3941.2022.0397$$gVol. 19, no. 11, p. 1586 - 1597$$n11$$p1586 - 1597$$tCancer biology & medicine$$v19$$x2095-3941$$y2022
000186219 909CO $$ooai:inrepo02.dkfz.de:186219$$pVDB
000186219 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000186219 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0d94e103911be59650920a32e859c2ba$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000186219 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)40c45b31a82f8311dd3a7363bd758720$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000186219 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000186219 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000186219 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000186219 9141_ $$y2022
000186219 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER BIOL MED : 2021$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2019-02-25T09:25:10Z
000186219 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2019-02-25T09:25:10Z
000186219 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2019-02-25T09:25:10Z
000186219 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ$$d2019-02-25T09:25:10Z
000186219 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER BIOL MED : 2021$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-18
000186219 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-18
000186219 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000186219 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000186219 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000186219 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000186219 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000186219 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000186219 980__ $$ajournal
000186219 980__ $$aVDB
000186219 980__ $$aI:(DE-He78)C070-20160331
000186219 980__ $$aI:(DE-He78)C120-20160331
000186219 980__ $$aI:(DE-He78)HD01-20160331
000186219 980__ $$aUNRESTRICTED